$CYDY Cashflow Statement | Understand Stock

$CYDY

$0.20 -$0.01 (5.05%) Close

$CYDY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to May 31, 2026	FY2025 12 months to May 31, 2025	FY2024 12 months to May 31, 2024	FY2023 12 months to May 31, 2023	FY2022 12 months to May 31, 2022
Cash flows from operating activities:
Net (loss) income
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation
Amortization of debt issuance costs
Standby equity purchase agreement non-cash commitment fee
Issuance costs for private placement of shares and warrants through placement agent
Amortization of discount on convertible notes
Warrants issued for legal settlement
Gain on restructuring of payables
Loss on derivatives
Inducement interest expense and non-cash finance charges
Non-cash finance charges
Loss on note extinguishment
Change in fair value of derivative liabilities
Inventory charge
Loss on induced conversion
Stock-based compensation
Intangible asset impairment charge
Changes in operating assets and liabilities:
Decrease (increase) in inventories
Prepaid expenses and other assets
Accounts payable, accrued expenses, and other liabilities

Net cash used in operating activities
Cash flows from investing activities:
Net cash provided by/used in investing activities
Cash flows from financing activities:
Proceeds from warrant transactions, net of offering costs
Proceeds from sale of common stock and warrants, net of issuance costs
Proceeds from warrant exercises
Proceeds from convertible note and warrant issuances, net of offering costs
Proceeds from standby equity purchase agreement, net of issuance costs
Proceeds from exercise of stock options
Proceeds from convertible notes payable, net
Proceeds held in trust
Cash paid for note payable
Net cash provided by financing activities
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure:
Cash paid for interest
Non-cash investing and financing transactions:
Derivative liability associated with warrants
Issuance of common stock for interest on convertible notes
Dividend paid in common stock on Series B and C convertible preferred stock conversions
Warrants issued to placement agent, recorded in additional paid-in capital
Warrants issued for surety bond backstop agreement
Deemed dividend on common stock issued due to down round provision, recorded in additional paid-in capital
Note conversion to common stock and warrants
Accrued dividends on Series C and D convertible preferred stock
Dividend paid in common stock on Series C convertible preferred stock conversions
Cashless exercise of warrants
Warrants issued to placement agent

Cash and cash equivalents consisted of the following:
Cash and cash equivalents
Restricted cash

Comments